Healthscore 1018·9 metrosupdated 3h ago
FDA Approves Lipfendra, a Groundbreaking Cholesterol-Lowering Pill
The FDA has approved Lipfendra, a new noninjectable pill from Merck that significantly reduces cholesterol levels in high-risk patients. This approval marks a shift from expensive injectable treatments to a more accessible oral medication.
Where it's breaking
Local coverage
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
New cholesterol-busting pill, costly but powerful, gets FDA's OK
FDA approves first-of-its-kind cholesterol pill
FDA Approves Lipfendra: First Noninjectable Cholesterol Pill for High-Risk Patients
FDA approves first-of-its-kind cholesterol pill
FDA Approves Lipfendra, First Oral Cholesterol Pill by Merck
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
- T2WUSA9
- T2WVEC (13News Now)
- T2The Virginian-Pilot
- T2Daily Press
- T2WLTX (CBS Columbia)
- T2Capital Gazette
- T2Baltimore Sun
- T2WBAL (NBC 11)
- T3Daily Local News (Chester County)
- T3Delaware County Daily Times
- T3Main Line Times
- T2Chicago Sun-Times
- T2Sun Sentinel (South Florida)
- T2Orange County Register
- T2San Bernardino Sun
- T2LA Daily News
- T2Long Beach Press-Telegram
- T2Pasadena Star-News
- T2Boston Herald
- T2Lowell Sun
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.